These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 21531791

  • 1. Chromosome 7p11.2 (EGFR) variation influences glioma risk.
    Sanson M, Hosking FJ, Shete S, Zelenika D, Dobbins SE, Ma Y, Enciso-Mora V, Idbaih A, Delattre JY, Hoang-Xuan K, Marie Y, Boisselier B, Carpentier C, Wang XW, Di Stefano AL, Labussière M, Gousias K, Schramm J, Boland A, Lechner D, Gut I, Armstrong G, Liu Y, Yu R, Lau C, Di Bernardo MC, Robertson LB, Muir K, Hepworth S, Swerdlow A, Schoemaker MJ, Wichmann HE, Müller M, Schreiber S, Franke A, Moebus S, Eisele L, Försti A, Hemminki K, Lathrop M, Bondy M, Houlston RS, Simon M.
    Hum Mol Genet; 2011 Jul 15; 20(14):2897-904. PubMed ID: 21531791
    [Abstract] [Full Text] [Related]

  • 2. Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies.
    Di Stefano AL, Enciso-Mora V, Marie Y, Desestret V, Labussière M, Boisselier B, Mokhtari K, Idbaih A, Hoang-Xuan K, Delattre JY, Houlston RS, Sanson M.
    Neuro Oncol; 2013 May 15; 15(5):542-7. PubMed ID: 23161787
    [Abstract] [Full Text] [Related]

  • 3. Two independent variants of epidermal growth factor receptor associated with risk of glioma in a Korean population.
    Baek IK, Cheong HS, Namgoong S, Kim JH, Kang SG, Yoon SJ, Kim SH, Chang JH, Kim LH, Shin HD.
    Sci Rep; 2022 Nov 08; 12(1):19014. PubMed ID: 36347915
    [Abstract] [Full Text] [Related]

  • 4. Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.
    Ostrom QT, Kinnersley B, Wrensch MR, Eckel-Passow JE, Armstrong G, Rice T, Chen Y, Wiencke JK, McCoy LS, Hansen HM, Amos CI, Bernstein JL, Claus EB, Il'yasova D, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Rubin JB, Lathia JD, Berens ME, Andersson U, Rajaraman P, Chanock SJ, Linet MS, Wang Z, Yeager M, GliomaScan consortium, Houlston RS, Jenkins RB, Melin B, Bondy ML, Barnholtz-Sloan JS.
    Sci Rep; 2018 May 09; 8(1):7352. PubMed ID: 29743610
    [Abstract] [Full Text] [Related]

  • 5. Practical molecular diagnostics in neuropathology: making a tough job a little easier.
    Horbinski C.
    Semin Diagn Pathol; 2010 May 09; 27(2):105-13. PubMed ID: 20860314
    [Abstract] [Full Text] [Related]

  • 6. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
    Ghasimi S, Wibom C, Dahlin AM, Brännström T, Golovleva I, Andersson U, Melin B.
    J Neurooncol; 2016 May 09; 127(3):483-92. PubMed ID: 26839018
    [Abstract] [Full Text] [Related]

  • 7. Genome-wide association study of glioma and meta-analysis.
    Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, Yeager M, Ahlbom A, Albanes D, Andersson U, Freeman LE, Buring JE, Butler MA, Braganza M, Carreon T, Feychting M, Fleming SJ, Gapstur SM, Gaziano JM, Giles GG, Hallmans G, Henriksson R, Hoffman-Bolton J, Inskip PD, Johansen C, Kitahara CM, Lathrop M, Liu C, Le Marchand L, Linet MS, Lonn S, Peters U, Purdue MP, Rothman N, Ruder AM, Sanson M, Sesso HD, Severi G, Shu XO, Simon M, Stampfer M, Stevens VL, Visvanathan K, White E, Wolk A, Zeleniuch-Jacquotte A, Zheng W, Decker P, Enciso-Mora V, Fridley B, Gao YT, Kosel M, Lachance DH, Lau C, Rice T, Swerdlow A, Wiemels JL, Wiencke JK, Shete S, Xiang YB, Xiao Y, Hoover RN, Fraumeni JF, Chatterjee N, Hartge P, Chanock SJ.
    Hum Genet; 2012 Dec 09; 131(12):1877-88. PubMed ID: 22886559
    [Abstract] [Full Text] [Related]

  • 8. Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials.
    Kros JM, Huizer K, Hernández-Laín A, Marucci G, Michotte A, Pollo B, Rushing EJ, Ribalta T, French P, Jaminé D, Bekka N, Lacombe D, van den Bent MJ, Gorlia T.
    J Clin Oncol; 2015 Jun 10; 33(17):1943-50. PubMed ID: 25918297
    [Abstract] [Full Text] [Related]

  • 9. Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies.
    Walsh KM, Anderson E, Hansen HM, Decker PA, Kosel ML, Kollmeyer T, Rice T, Zheng S, Xiao Y, Chang JS, McCoy LS, Bracci PM, Wiemels JL, Pico AR, Smirnov I, Lachance DH, Sicotte H, Eckel-Passow JE, Wiencke JK, Jenkins RB, Wrensch MR.
    Genet Epidemiol; 2013 Feb 10; 37(2):222-8. PubMed ID: 23280628
    [Abstract] [Full Text] [Related]

  • 10. EGFR gene variants are associated with specific somatic aberrations in glioma.
    Wibom C, Ghasimi S, Van Loo P, Brännström T, Trygg J, Lau C, Henriksson R, Bergenheim T, Andersson U, Rydén P, Melin B.
    PLoS One; 2012 Feb 10; 7(12):e47929. PubMed ID: 23236348
    [Abstract] [Full Text] [Related]

  • 11. Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas.
    Wang XW, Boisselier B, Rossetto M, Marie Y, Idbaih A, Mokhtari K, Gousias K, Hoang-Xuan K, Delattre JY, Simon M, Labussière M, Sanson M.
    Cancer; 2013 Feb 15; 119(4):806-13. PubMed ID: 23184331
    [Abstract] [Full Text] [Related]

  • 12. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
    Brito C, Azevedo A, Esteves S, Marques AR, Martins C, Costa I, Mafra M, Bravo Marques JM, Roque L, Pojo M.
    BMC Cancer; 2019 Oct 17; 19(1):968. PubMed ID: 31623593
    [Abstract] [Full Text] [Related]

  • 13. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.
    Andersson U, Schwartzbaum J, Wiklund F, Sjöström S, Liu Y, Tsavachidis S, Ahlbom A, Auvinen A, Collatz-Laier H, Feychting M, Johansen C, Kiuru A, Lönn S, Schoemaker MJ, Swerdlow AJ, Henriksson R, Bondy M, Melin B.
    Acta Oncol; 2010 Aug 17; 49(6):767-75. PubMed ID: 20446891
    [Abstract] [Full Text] [Related]

  • 14. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
    Bale TA, Jordan JT, Rapalino O, Ramamurthy N, Jessop N, DeWitt JC, Nardi V, Alvarez MM, Frosch M, Batchelor TT, Louis DN, Iafrate AJ, Cahill DP, Lennerz JK.
    Neuro Oncol; 2019 May 06; 21(5):596-605. PubMed ID: 30496526
    [Abstract] [Full Text] [Related]

  • 15. Relationship between gene amplification and chromosomal deviations in malignant human gliomas.
    Bigner SH, Wong AJ, Mark J, Muhlbaier LH, Kinzler KW, Vogelstein B, Bigner DD.
    Cancer Genet Cytogenet; 1987 Nov 06; 29(1):165-70. PubMed ID: 3478127
    [Abstract] [Full Text] [Related]

  • 16. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.
    Viana-Pereira M, Moreno DA, Linhares P, Amorim J, Nabiço R, Costa S, Vaz R, Reis RM.
    Mol Biol Rep; 2020 Feb 06; 47(2):877-886. PubMed ID: 31721021
    [Abstract] [Full Text] [Related]

  • 17. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.
    Wu Q, Peng Y, Zhao X.
    Mol Neurobiol; 2016 Sep 06; 53(7):4397-405. PubMed ID: 26243184
    [Abstract] [Full Text] [Related]

  • 18. Sex-specific gene and pathway modeling of inherited glioma risk.
    Ostrom QT, Coleman W, Huang W, Rubin JB, Lathia JD, Berens ME, Speyer G, Liao P, Wrensch MR, Eckel-Passow JE, Armstrong G, Rice T, Wiencke JK, McCoy LS, Hansen HM, Amos CI, Bernstein JL, Claus EB, Houlston RS, Il'yasova D, Jenkins RB, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Andersson U, Rajaraman P, Chanock SJ, Linet MS, Wang Z, Yeager M, GliomaScan consortium, Melin B, Bondy ML, Barnholtz-Sloan JS.
    Neuro Oncol; 2019 Jan 01; 21(1):71-82. PubMed ID: 30124908
    [Abstract] [Full Text] [Related]

  • 19. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y, Yoshimoto T, Sekiya T.
    Oncogene; 1995 Nov 16; 11(10):2145-9. PubMed ID: 7478535
    [Abstract] [Full Text] [Related]

  • 20. Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors.
    Kafadar A, Küçükhüseyin Ö, Turan S, Yenilmez EN, Tunoglu S, Zeybek U, Kaynar MY, Kemerdere R, Yaylim I.
    Anticancer Res; 2015 Jul 16; 35(7):3933-42. PubMed ID: 26124340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.